Aclaris Therapeutics (ACRS) EBIT Margin (QoQ) (2017 - 2026)
Aclaris Therapeutics (ACRS) EBIT Margin (QoQ) (2017 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - |
| 10 | Aclaris Therapeutics | 705.88 Mn | 705.88 Mn | 1.60 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 64,370.00 |
| Dec 31, 2025 | -123,570.00 |
| Sep 30, 2025 | 51,608.00 |
| Jun 30, 2025 | 20,698.00 |
| Mar 31, 2025 | -16,076.00 |
| Dec 31, 2024 | -84,120.00 |
| Sep 30, 2024 | 22,378.00 |
| Jun 30, 2024 | 32,474.00 |
| Mar 31, 2024 | -76,642.00 |
| Dec 31, 2023 | 31,716.00 |
| Sep 30, 2023 | 136,205.00 |
| Jun 30, 2023 | -51,878.00 |
| Mar 31, 2023 | -80,840.00 |
| Dec 31, 2022 | -26,531.00 |
| Sep 30, 2022 | 126,419.00 |
| Jun 30, 2022 | -7,271.00 |
| Mar 31, 2022 | 22,394.00 |
| Dec 31, 2021 | -30,186.00 |
| Sep 30, 2021 | -23,616.00 |
| Jun 30, 2021 | 61,829.00 |